Klaus J. Busam

41.9k total citations · 5 hit papers
426 papers, 24.8k citations indexed

About

Klaus J. Busam is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Klaus J. Busam has authored 426 papers receiving a total of 24.8k indexed citations (citations by other indexed papers that have themselves been cited), including 320 papers in Oncology, 126 papers in Molecular Biology and 103 papers in Dermatology. Recurrent topics in Klaus J. Busam's work include Cutaneous Melanoma Detection and Management (220 papers), Nonmelanoma Skin Cancer Studies (73 papers) and Melanoma and MAPK Pathways (72 papers). Klaus J. Busam is often cited by papers focused on Cutaneous Melanoma Detection and Management (220 papers), Nonmelanoma Skin Cancer Studies (73 papers) and Melanoma and MAPK Pathways (72 papers). Klaus J. Busam collaborates with scholars based in United States, Australia and Germany. Klaus J. Busam's co-authors include Boris C. Bastian, Achim A. Jungbluth, John A. Curtin, Daniel G. Coit, Mary S. Brady, Allan C. Halpern, Daniel Pinkel, Heinz Kutzner, Kristin Iversen and Melissa Pulitzer and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Klaus J. Busam

416 papers receiving 24.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distinct Sets of Genetic Alterations in Melanoma

2005 1.9k citations John A. Curtin, Klaus J. Busam et al. profile →
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images

2019 1.4k citations Klaus J. Busam et al. profile →
Somatic Activation of KIT in Distinct Subtypes of Melanoma

2006 1.1k citations John A. Curtin, Klaus J. Busam et al. Journal of Clinical Oncology profile →
Mutations in GNA11 in Uveal Melanoma

2010 1.1k citations Thomas Wiesner, Klaus J. Busam et al. profile →
Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution

2005 533 citations Peter J. Allen, Klaus J. Busam et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Klaus J. Busam United States	80	16.6k	9.3k	4.2k	3.3k	3.2k	426	24.8k
Richard A. Scolyer Australia	84	21.3k 1.3×	13.3k 1.4×	6.6k 1.6×	2.7k 0.8×	4.1k 1.3×	707	30.6k
Jeffrey E. Gershenwald United States	72	19.6k 1.2×	9.8k 1.1×	5.0k 1.2×	3.1k 0.9×	5.7k 1.8×	283	25.5k
Axel Hauschild Germany	68	13.3k 0.8×	10.0k 1.1×	4.3k 1.0×	3.1k 0.9×	3.6k 1.1×	431	20.5k
Boris C. Bastian United States	70	12.0k 0.7×	12.6k 1.4×	3.4k 0.8×	1.6k 0.5×	1.3k 0.4×	201	20.8k
Vernon K. Sondak United States	71	16.6k 1.0×	8.3k 0.9×	5.7k 1.4×	1.9k 0.6×	3.4k 1.1×	432	22.6k
Víctor G. Prieto United States	65	8.8k 0.5×	4.8k 0.5×	2.1k 0.5×	4.0k 1.2×	3.3k 1.0×	556	16.0k
Martín C. Mihm United States	94	20.4k 1.2×	9.2k 1.0×	8.2k 1.9×	7.7k 2.3×	5.4k 1.7×	456	34.5k
Alexander M.M. Eggermont Netherlands	72	18.5k 1.1×	9.4k 1.0×	6.7k 1.6×	1.8k 0.6×	3.5k 1.1×	389	25.8k
Alistair J. Cochran United States	56	12.0k 0.7×	4.8k 0.5×	3.7k 0.9×	1.9k 0.6×	3.8k 1.2×	182	16.6k
Daniel G. Coit United States	83	17.9k 1.1×	6.1k 0.7×	3.3k 0.8×	2.1k 0.7×	4.8k 1.5×	326	27.9k

Countries citing papers authored by Klaus J. Busam

Since Specialization

Citations

This map shows the geographic impact of Klaus J. Busam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus J. Busam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus J. Busam more than expected).

Fields of papers citing papers by Klaus J. Busam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus J. Busam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus J. Busam. The network helps show where Klaus J. Busam may publish in the future.

Co-authorship network of co-authors of Klaus J. Busam

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus J. Busam. A scholar is included among the top collaborators of Klaus J. Busam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus J. Busam. Klaus J. Busam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frosina, Denise, et al.. (2024). Detecting Monkeypox Virus by Immunohistochemistry. Journal of Cutaneous Pathology. 52(3). 244–249.

Luo, Li, Arshi Arora, Venkatraman Seshan, et al.. (2023). Pathway Alterations in Stage II/III Primary Melanoma. JCO Precision Oncology. 7(7). e2200439–e2200439. 2 indexed citations

Busam, Klaus J., et al.. (2023). Compound clear cell sarcoma with EWSR1::CREM fusion. Journal of Cutaneous Pathology. 50(12). 1065–1069. 8 indexed citations

Lezcano, Cecilia, Achim A. Jungbluth, Kishwer S. Nehal, Travis J. Hollmann, & Klaus J. Busam. (2018). PRAME Expression in Melanocytic Tumors. The American Journal of Surgical Pathology. 42(11). 1456–1465. 245 indexed citations

Busam, Klaus J., Ricardo E. Vilain, Trina Lum, et al.. (2016). Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation. The American Journal of Surgical Pathology. 40(6). 786–795. 39 indexed citations

Marušić, Zlatko, Marija Buljan, & Klaus J. Busam. (2015). Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1‐associated cancer susceptibility syndrome. Journal of Cutaneous Pathology. 42(6). 406–412. 24 indexed citations

Yélamos, Oriol, Klaus J. Busam, Christina Lee, et al.. (2015). Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma. Journal of Cutaneous Pathology. 42(11). 796–806. 12 indexed citations

Lee, Erica H., et al.. (2012). Clinical Value of Paraffin Sections in Association with Mohs Micrographic Surgery for Nonmelanoma Skin Cancers. Dermatologic Surgery. 38(10). 1631–1638. 17 indexed citations

Zimmer, Lisa, Uwe Hillen, Elisabeth Livingstone, et al.. (2012). Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition. Journal of Clinical Oncology. 30(19). 2375–2383. 167 indexed citations

10.

Fields, Ryan C., Klaus J. Busam, Joanne F. Chou, et al.. (2011). Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer. 118(13). 3311–3320. 73 indexed citations

11.

Shea, Sofia M., Mark S. Eller, William H. Westra, et al.. (2011). Neuropilin-2: a novel biomarker for malignant melanoma?. Human Pathology. 43(3). 381–389. 24 indexed citations

12.

Surguladze, David, Dhanvanthri S. Deevi, Erik Corcoran, et al.. (2009). Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice. Cancer Research. 69(14). 5643–5647. 40 indexed citations

13.

Taylor, Rebecca C., Ami B. Patel, Katherine S. Panageas, Klaus J. Busam, & Mary S. Brady. (2007). Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma. Journal of Clinical Oncology. 25(7). 869–875. 224 indexed citations

14.

Busam, Klaus J., Allan C. Halpern, & Ashfaq A. Marghoob. (2006). Malignant Melanoma Metastatic to a Basal Cell Carcinoma Simulating the Pattern of a Basomelanocytic Tumor. The American Journal of Surgical Pathology. 30(1). 133–136. 23 indexed citations

15.

Agero, Anna Liza C., Klaus J. Busam, Cristiane Benvenuto-Andrade, et al.. (2006). Reflectance confocal microscopy of pigmented basal cell carcinoma. Journal of the American Academy of Dermatology. 54(4). 638–643. 111 indexed citations

16.

Curtin, John A., Klaus J. Busam, Daniel Pinkel, & Boris C. Bastian. (2006). Somatic Activation of KIT in Distinct Subtypes of Melanoma. Journal of Clinical Oncology. 24(26). 4340–4346. 1124 indexed citations breakdown →

17.

AMIN, SNEHAL P., et al.. (2004). Multiple Subclinical Syringomatous Proliferations Encountered during Mohs Surgery for Basal Cell Carcinoma. Dermatologic Surgery. 30(11). 1420–1423. 5 indexed citations

18.

Ferrone, Cristina R., Katherine S. Panageas, Klaus J. Busam, Mary Sue Brady, & Daniel G. Coit. (2002). Multivariate prognostic model for patients with thick cutaneous melanoma: Importance of sentinel lymph node status. Annals of Surgical Oncology. 9(7). 637–645. 100 indexed citations

19.

Busam, Klaus J.. (2001). Lack of Relevant Information for Tumor Staging in Pathology Reports of Primary Cutaneous Melanoma. American Journal of Clinical Pathology. 115(5). 743–746. 14 indexed citations

20.

Jungbluth, Achim A., Klaus J. Busam, William L. Gerald, et al.. (1998). A103. The American Journal of Surgical Pathology. 22(5). 595–602. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact